BSE filing, NSE: ITCHOTELS. Summary written from the filing by ALFA Finder's alert engine.
ITC Hotels Ltd: key numbers
- Share price
- ₹164.40
- Market cap
- ₹34,248 Cr
- Revenue (annual)
- ₹4,139 Cr
- Net profit (annual)
- ₹816.9 Cr
- P/E (TTM)
- 36.7×Sector 43.7×
- Promoter holding
- 39.85%+0.00% QoQ
- FII holding
- 11.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ITC Hotels Ltd
All →ITC Hotels Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹1,054 cr (+26%), EBITDA ₹337 cr (+37%), PAT ₹203 cr (+52%). Asset-right expansion continues.
ITC Hotels Merger & Restructuring Worth ₹20 Cr
ITC Hotels' board approved incorporating a wholly owned Dubai subsidiary in hospitality, with up to ₹20 Crore capital infusion. The subsidiary will operate hotels and restaurants, subject to regulatory approvals.
- Value
- ₹20.00 Cr
ITC Hotels Q2 FY27 Results: Net Profit ₹202.7 Cr, Up 52.1% YoY
ITC Hotels Ltd reported revenue from operations of ₹1,054 Cr (+25.6% YoY) and net profit of ₹202.7 Cr (+52.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹202.7 Cr · +52.1% YoY
ITC Hotels Board Meeting Date
ITC Hotels has intimated a Board Meeting on 26 October 2026 to approve Q2 FY27 unaudited standalone and consolidated financial results. No decision has been taken yet; the agenda is proposed only.
ITC Hotels Employee Stock Options
ITC Hotels issued 1,31,990 equity shares following the exercise of 13,199 employee stock options. This allotment increases the company's paid-up share capital.
ITC Hotels Other Announcement
ITC Hotels Limited has filed the mandatory quarterly certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming share dematerialization status.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.